Concepedia

Michele McElvain

MM

Statistics

Publications

13

Citations

565

H-Index

13

Active since

1996

Affiliations

Amgen (United States)(Current)

Epix Pharmaceuticals (United States)

Integrated BioTherapeutics (United States)

Michele McElvain is an author at Amgen (United States) specializing in medicine, pharmacotherapy, and pharmacology.

ORCID

Top concepts

Publications per year

1996–2022

13

Publications

13

Potent hFPRL1 (ALXR) agonists as potential anti-inflammatory agents

Roland W. Bürli, Han Xu, Xiaoming Zou et al. · Bioorganic & Medicinal Chemistry Letters · 2006 · 125 citations · Full text

, , +6

Osteoblast Precursor Cells are Found in CD34 <sup>+</sup> Cells from Human Bone Marrow

J.‐L. Chen, P Hunt, Michele McElvain et al. · Stem Cells · 1997 · 111 citations · Full text

Discovery of AMG 369, a Thiazolo[5,4-<i>b</i>]pyridine Agonist of S1P<sub>1</sub> and S1P<sub>5</sub>

Victor J. Cee, Mike Frohn, Brian A. Lanman et al. · ACS Medicinal Chemistry Letters · 2010 · 54 citations · Full text

, , +17

A carcinoembryonic antigen-specific cell therapy selectively targets tumor cells with HLA loss of heterozygosity in vitro and in vivo

Mark L. Sandberg, Xueyin Wang, Aaron D. Martin et al. · Science Translational Medicine · 2022 · 50 citations

Functional arrays of human pluripotent stem cell-derived cardiac microtissues

Nimalan Thavandiran, Christopher M. Hale, Patrick H. Blit et al. · Scientific Reports · 2020 · 47 citations · Full text

1–5 of 13